Annovis Bio Correlations
ANVS Stock | USD 1.74 0.06 3.33% |
The current 90-days correlation between Annovis Bio and Reviva Pharmaceuticals Holdings is 0.08 (i.e., Significant diversification). The correlation of Annovis Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Annovis Bio Correlation With Market
Significant diversification
The correlation between Annovis Bio and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Annovis Bio and DJI in the same portfolio, assuming nothing else is changed.
Annovis |
Moving together with Annovis Stock
0.89 | ILMN | Illumina | PairCorr |
0.69 | INZY | Inozyme Pharma | PairCorr |
0.9 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.81 | ADTX | Aditxt Inc | PairCorr |
0.76 | STRO | Sutro Biopharma | PairCorr |
0.84 | TCRX | Tscan Therapeutics | PairCorr |
0.74 | TERN | Terns Pharmaceuticals | PairCorr |
0.78 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.63 | CTMX | CytomX Therapeutics | PairCorr |
0.75 | DAWN | Day One Biopharmaceu | PairCorr |
0.69 | TLKMF | Telkom Indonesia Tbk | PairCorr |
Moving against Annovis Stock
0.78 | PHGE | Biomx Inc | PairCorr |
0.73 | OPT | Opthea | PairCorr |
0.69 | FENC | Fennec Pharmaceuticals | PairCorr |
0.64 | LTRN | Lantern Pharma | PairCorr |
0.59 | GANX | Gain Therapeutics | PairCorr |
0.45 | CUE | Cue Biopharma | PairCorr |
0.41 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.53 | DBVT | DBV Technologies Earnings Call This Week | PairCorr |
0.83 | EC | Ecopetrol SA ADR | PairCorr |
0.78 | T | ATT Inc Aggressive Push | PairCorr |
0.75 | GPI | Group 1 Automotive | PairCorr |
0.73 | OBI | Ondine Biomedical | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Annovis Stock performing well and Annovis Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Annovis Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SAVA | 5.29 | (2.05) | 0.00 | (1.65) | 0.00 | 8.17 | 107.29 | |||
AXSM | 2.70 | 0.52 | 0.23 | 0.53 | 2.07 | 6.70 | 25.26 | |||
RVPH | 6.04 | 0.56 | 0.06 | 0.18 | 8.59 | 15.38 | 67.62 | |||
MCRB | 3.84 | 0.27 | 0.07 | 0.16 | 3.42 | 8.33 | 28.23 | |||
AVXL | 4.29 | 0.17 | 0.03 | 0.12 | 5.86 | 8.51 | 44.63 | |||
IOVA | 2.63 | (0.58) | 0.00 | (0.69) | 0.00 | 4.99 | 19.16 | |||
NVAX | 2.95 | (0.06) | 0.00 | (11.63) | 0.00 | 8.15 | 22.04 | |||
ANIX | 3.22 | 0.06 | 0.02 | 0.05 | 3.24 | 7.14 | 23.09 | |||
TFFP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
IMNM | 3.64 | 0.15 | 0.04 | 0.08 | 3.92 | 8.11 | 25.29 |
Annovis Bio Corporate Management
Blake Jensen | Head Quality | Profile | |
Reid McCarthy | Independent Director | Profile | |
Cheng Fang | Senior Development | Profile | |
Melissa Gaines | Senior Operations | Profile | |
Mark White | Independent Director | Profile | |
William CPA | Chief Officer | Profile | |
Hilda Maibach | Senior Statistics | Profile |